CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Mar. 31, 2013	Mar. 31, 2012
Cash flows from operating activities:
Net income (loss)	$ 28,519	$ (50,459)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization	65,823	92,510
Equity in loss of affiliated companies	15,348	5,688
Deferred income taxes	14,855	(4,981)
Accumulated other comprehensive income reclassification adjustments (Note 5)	(33,842)
Goodwill impairment		78,426
Stock-based compensation	4,723	6,065
Amortization of debt discount and financing costs	5,336	4,974
Other noncash items affecting earnings	1,500	925
Changes in operating assets and liabilities, excluding the effects of acquisitions	(20,522)	(30,104)
Net cash provided by operating activities	81,740	103,044
Cash flows from investing activities:
Capital expenditures	(72,554)	(65,619)
Proceeds from sale of assets	220	405
Asset acquisitions, net of cash acquired		(2,225)
Proceeds from loans and investments	131,054	2,315
Restricted cash used to collateralize insurance reserves	(24,500)
Net cash provided by (used in) investing activities	34,220	(65,124)
Cash flows from financing activities:
Borrowings on revolving credit facilities	5,200	427,800
Payments on revolving credit facilities	(5,200)	(427,800)
Repayments of long-term debt and capital lease obligations	(22,985)	(23,801)
Repurchase of common stock	(14,868)
Dividends paid	(10,310)	(10,405)
Net cash used in financing activities	(48,163)	(34,206)
Effect of exchange rate changes on cash and cash equivalents	569	(2,394)
Increase in cash and cash equivalents	68,366	1,320
Cash and cash equivalents:
Beginning of period	111,943	96,263
End of period	$ 180,309	$ 97,583